The Hematology/Oncology fellowship program available at Michigan State University is accredited by the ACGME.

During the first year, subspecialty residents are predominately involved with the care of hematology and oncology patients. In the second year, subspecialty residents are encouraged to develop a research project with one of the faculty members.

Out-patient clinical activities are located at the Karmanos Cancer Institute at McLaren Greater Lansing, an affiliate of McLaren Healthcare Corporation. In-patients are hospitalized in special oncology units staffed by oncology nurses, clinical pharmacists, physicians and occupational therapists. In addition, statewide hemophilia clinics are available in the spring, summer, and fall for interested subspecialty residents.

The Hematology/Oncology Fellowship Program offers multiple opportunities for clinical and research experience. Michigan State University is a member of the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Southwest Oncology Group (SWOG) and the MSU Cancer Treatment Consortium (MSU CTC), a clinical trial consortium composed of practicing Michigan oncologists. These groups offer opportunities for participation in clinical oncology protocols. Interested subspecialty fellows are encouraged to design and implement clinical protocols through one of these protocol groups.

Multiple opportunities exist for training in basic sciences with research in the fields of carcinogenesis, cancer pharmacology, tumor biology, tumor immunology and other oncology related areas. Hematology research areas include clinical hemophilia, biochemistry of humoral clotting factors, platelet immunology, iron overload, immunology of tissue compatibility and other areas.

Applicants must successfully complete an Internal Medicine residency program in the United States before they are eligible to apply for a subspecialty fellowship.

For additional information, please contact Christina Bott, Program Coordinator at (517) 353-4811 or Christina.bott@hc.msu.edu.